TrialBritish journal of cancer2019

Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study.

Tingyan Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.